Add BrightSurf on Google Email

Science News Archive January 2017 - Page 19


Page 19 of 35

Are you ready to explore your baby's genome?

A national consortium of researchers is studying the pros and cons of genome sequencing for newborn health, raising questions about parental responsibility and child autonomy. The four studies across the US aim to develop evidence for guidelines on effectively incorporating new technology into newborn screening or care.

SourceBrigham and Women's Hospital·JournalPEDIATRICS·DateJan 17, 2017

The devil is in the details

In mouse models, NRP2a inhibited tumor cell proliferation while NRP2b promoted metastasis and progression. Cancer stem cells were also reduced in NRP2b knockdown models, providing new insights into lung cancer progression. The study suggests that targeting NRP2b may lead to improved therapies for non-small cell lung cancer.

SourceMedical University of South Carolina·JournalScience Signaling·DateJan 17, 2017

Plant-derived products may help fight HBV

Researchers have discovered that plant-derived products, such as proanthocyanidin (PAC), can inhibit hepatitis B virus (HBV) entry into host cells and potentially treat treatment-resistant strains. PAC also enhances the effectiveness of antiviral drugs like tenofovir, offering a promising new approach to combatting HBV.

SourceWiley·JournalHepatology·DateJan 17, 2017

Tigers could roam again in Central Asia, scientists say

Researchers have identified two promising sites in Kazakhstan where Amur tigers could be reintroduced to Central Asia. The Ili River delta and adjacent southern coast of Balkhash Lake are considered suitable habitats, covering approximately 7,000 square kilometers. To ensure a sustainable future for both tigers and local communities, a...

SourceSUNY College of Environmental Science and Forestry·JournalBiological Conservation·DateJan 17, 2017

Blocking neuron signaling pathway could lead to new treatments for peripheral neuropathy

Researchers identified a molecular signaling pathway that promotes sensory neuron growth and prevents or reverses peripheral neuropathy in cell and rodent models of type 1 and 2 diabetes, chemotherapy-induced neuropathy, and HIV. Anti-muscarinic drugs already approved for other conditions may offer new treatment options.

SourceUniversity of California - San Diego·JournalJournal of Clinical Investigation·DateJan 17, 2017

Commercial interests may drown out patients' voices

A growing body of evidence suggests that patient advocacy groups funded by pharmaceutical companies may promote treatments that serve the companies' interests rather than patients' needs. Studies have found that these groups are often biased towards funding sources, with some reporting pressure to conform to industry positions.

SourceUniversity of Sydney·JournalJAMA Internal Medicine·DateJan 17, 2017

Community-acquired pneumonia can spread year-round

A study of 12 years of community-acquired pneumonia data found that while the condition occurs throughout all seasons, winter is the peak season for pathogen variation. The research suggests that community-acquired pneumonia can no longer be classified as a seasonal disease.

SourceWiley·JournalRespirology·DateJan 17, 2017

Cell biology: Take the mRNA train

Researchers have characterized the structure of a macromolecular complex involved in mRNA transport, showing how RNAs are recognized and bound by binding proteins in the nucleus. The complex allows for the specific recognition and transport of mRNAs from the cell nucleus to the cytoplasm.

SourceLudwig-Maximilians-Universität München·JournalNature Structural & Molecular Biology·DateJan 17, 2017

First of its kind cancer stem cell research unlocks clues to treatment resistance

Researchers at Trinity College Dublin have discovered a link between the loss of miR-17 and oesophageal tumour resistance to radiotherapy. Higher numbers of cancer stem cells formed larger, more aggressive tumours and were more resistant to radiation-induced cell death. Synthetic miR-17 may enhance radiotherapy effectiveness in patients.

SourceTrinity College Dublin·JournalOncoTargets and Therapy·DateJan 17, 2017

Unveiling the biology behind nonalcoholic fatty liver disease

Researchers at EPFL have identified a key player in the development of nonalcoholic fatty liver disease (NAFLD), a condition characterized by excessive fat accumulation in the liver. The study found that impaired SUMOylation of nuclear receptor LRH-1 promotes NAFLD, highlighting potential new treatments and biomarkers for the disease.

SourceEcole Polytechnique Fédérale de Lausanne·JournalJournal of Clinical Investigation·DateJan 17, 2017

How solvents affect the skin

Researchers studied how solvents affect skin molecules, revealing changes in fluid state and interactions with added components. The findings improve understanding of molecular mechanisms, enabling more efficient regulation of skin properties.

SourceLund University·JournalProceedings of the National Academy of Sciences·DateJan 17, 2017